skip to main content
Give

Michael J. Miller

Michael J. Miller
Michael J. Miller, RPh, DrPH, FAPhA

Associate Professor of Pharmaceutical Sciences

Contact

Texas A&M Irma Lerma Rangel College of Pharmacy
Mail Stop 1114 159 Reynolds Medical Building
College Station, TX 77843
mjmiller@tamu.edu
Phone: 979.436.0294
Fax: 979.436.0087

Education and Training

  • Department of Behavioral and Community Health Sciences (formerly Health Services Administration), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15260 Dissertation Title: The Relationship Between a Synthetic Estimate of Functional Health Literacy and Preventive Health Care Use in a National Sample of Elderly. Pittsburgh, PA: University of Pittsburgh; 2004. [electronic resource] http://etd.library.pitt.edu/ETD/available/etd-12022004-001521/. Proquest Document ID: 845748421. Publication Number: AAT3158629 Directed by: Howard B. Degenholtz, PhD, Doctor of Public Health (DrPH), 2004
  • College of Pharmacy, The University of Arizona, Tucson, AZ 85721 Thesis: "A Retrospective Analysis of the Clinical and Economic Impact of a Tobacco Cessation Program for Active Duty Military Service Members" Directed by: JoLaine R. Draugalis, Ph.D., Master of Science Degree in Pharmacy Administration, 1995
  • School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15260 Cum Laude Honors, Bachelor of Science Degree in Pharmacy, 1988

Research Interests

  • Methodologic interests include the identification, development, application, and evaluation of practical social, behavioral and clinical strategies to optimize the medication use process
  • Clinical research interests focus on cardiovascular-related disease, rheumatology, depression, and infectious disease

Teaching Interests

  • Design, analysis and interpretation of research to ensure appropriate application to healthcare decision-making
  • The role of pharmacists in the evolving US health care system
  • The social and behavioral aspects of the medication use process

Awards, Recognition and Service

  • Graduate, American Association of Colleges of Pharmacy Academic Research Fellows Program (2015)
  • Fellow, American Pharmacists Association (2012)
  • Top Reviewer for 2009, Journal of Research in Social and Administrative Pharmacy (2010)
  • Drake College of Pharmacy and Health Sciences Mentor of the Year Award (2008)
  • Omicron Chapter of Delta Omega Best Dissertation of the Year in the Department of Behavioral and Community Health Sciences, Graduate School of Public Health, University of Pittsburgh (2005)
  • Special Contribution Award - Workload Specification and Task Measurement Project Department of Veterans Affairs (1997)
  • Outstanding Graduate Teaching Assistant Award, University of Arizona Foundation - College of Pharmacy (1993/1994)
  • Rho Chi Pharmacy Professional Honor Society - Alpha Psi Chapter (1994)
  • Air Force Commendation Medal with First Oak Leaf Cluster (1992)
  • Air Force Commendation Medal (1991)

Memberships

  • Guest Editor, Research in Social and Administrative Pharmacy, Special Issue on Interventional Approaches to Health Literacy in Pharmacy Practice and Education (3/2017 to Present)
  • Member, Editorial Advisory Board, Research in Social and Administrative Pharmacy (3/2006 to 11/2014; 3/2016 to Present)
  • Chair, ASHP Research and Education Foundation Research Advisory Panel (10/2010 to Present)
  • Member, ASHP Research and Education Foundation Research Advisory Panel (2007 to Present)
  • Member, Editorial Advisory Board, Journal of the American Pharmacists Association (3/2013 to 3/2016)
  • Guest Editor, Research in Social and Administrative Pharmacy, Special Themed Issue – Health Literacy (3/2012 to 9/2013)

Representative Publications

  • ResearchGate
  • Google Scholar
  • ORCID
  • Thiessen K, Lloyd AE, Miller MJ, Homco, J, O’Neal KS, Gildon B. Infection. Assessing guideline-concordant prescribing for community-acquired pneumonia. International Journal of Clinical Pharmacy. 5/30/2017. doi: 10.1007/s11096-017-0489-4.
  • Bulkley C, Miller MJ, Draugalis JR, Nussbaum B, Bush C. Preparing Advanced Practice Pharmacists for Research: Needs Assessment and Training Program Development. Am J Health-Syst Pharm. Accepted 5/12/2017.
  • Weech-Maldonado R, Miller MJ, Lord JC. The Relationships among Socio-Demographics, Perceived Health, and Happiness. Applied Research in Quality of Life. 3/31/2017. doi 10.1007/s11482-017-9517-8
  • Bulkley CF, Miller MJ, Draugalis JR. Developing and improving residency research training. Am J Health-Syst Pharm. 2017; 74:152-61.
  • David CM, O'Neal KS, Miller MJ, Johnson JL, Lloyd AE. A literacy-sensitive approach to improving antibiotic understanding in a community-based setting. Int J Pharm Pract. 1/18/2017. doi:10.1111/ijpp.12332.
  • Houser SH, Au DW, Miller MJ, Chen L, Outman RC, Ray MN, Saag KG, Weech-Maldonado R. Socio-Demographic Differences in Risk Information Seeking Sources for Non-Steroidal Anti-inflammatory Drugs (NSAIDS).  International Journal of Medical Informatics. 2016; 94:222-227.  http://dx.doi.org/10.1016/j.ijmedinf.2016.07.017.
  • Miller MJ, Weech-Maldonado R, Outman RC, Ray MN, Gary LC, Chen L, Cobaugh DJ, Allison JJ, Saag K. Evaluating the Effectiveness of a Patient Storytelling DVD Intervention to Encourage Physician-Patient Communication About Nonsteroidal Anti-Inflammatory Drug (NSAID) Use. Patient Educ Couns. Accepted 6/16/2016.  http://dx.doi.org/10.1016/j.pec.2016.06.013. 
  • Miller MJ, Burns CF, Kapusnik-Uner J, Carreno R, Matuszewski KA. Depression Screening for Medications with Mental Health Risk. Depression Screening for Prescribed Medications with Mental Health Risk: Considerations for Clinical Decision Support, Workflow Redesign, and Health Information Exchange Arrangements. Res Social Adm Pharm. Accepted 6/16/2016.  http://dx.doi.org/10.1016/j.sapharm.2016.06.008 
  • Danila MI, Outman RC, Rahn EJ, Mudano AS, Thomas TF, Redden DT, Allison JJ, Anderson FA, Anderson JP, Cram PM, Curtis JR, Fraenkel L, Greenspan SL, LaCroix AZ, Majumdar SR, Miller MJ, Nieves JW, Safford MM, Silverman SL, Siris ES, Solomon DH, Warriner AH, Watts NB, Yood RA, Saag KG. A Multi-Modal Intervention for Activating Patients at Risk for Osteoporosis (APROPROS): Rationale, Design, and Uptake of Online Study Intervention Material. Contemporary Clinical Trials Communications. 2016; 4: 14-24.       http://dx.doi.org/10.1016/j.conctc.2016.06.010
  • Capino AC, Miller JL, Hughes KM, Miller MJ, Johnson PN. Caregiver perception, self-efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome. J Pharm Technol. 2015; 1-12. DOI: 10.1177/8755122515622030 [original research].
  • Downes JM, O’Neal KS, Miller MJ, Johnson JL, Gildon BL, Weisz MA. Identifying opportunities to improve medication management in transitions of care. Am J Health Syst Pharm. 2015; 72(17 Suppl 2):S58-69.
  • Mittal M, Harrison DL, Thompson DM, Miller MJ, Farmer KC, Ng YT. An Evaluation of Three Statistical Estimation Methods for Assessing Health Policy Effects on Prescription Drug Claims. Res Social Adm Pharm. Published online 4/3/2015. doi:10.1016/j.sapharm.2015.03.004.
  • Cobaugh DJ, Miller MJ, Pham TT, Krenzelok EP. Risk of Major Morbidity and Death in Older Adults with Suicidal Intent: A Cross –Sectional Analysis from the National Poison Data System, 2000-2009. J Am Geriatr Soc. 2015;63:501-507.
  • van den Bogert CA, Miller MJ, Cobaugh DJ, Chen L, Allison JJ, Saag KG. Screening Questions for Nonsteroidal Anti-Inflammatory Drug (NSAID) Risk Knowledge. J Patient Saf. Published online 10/1/2014. doi: 10.1097/PTS.0000000000000143
  • Kim M, Lloyd A, Condren M, Miller MJ. Beyond Antibiotic Selection: Concordance with the IDSA Guidelines for Uncomplicated Urinary Tract Infections. Infection. Published online 7/18/2014. DOI 10.1007/s15010-014-0659-4. 
  • Miller MJ, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. A Group Randomized Trial of Shared Decision-Making for Nonsteroidal Anti-inflammatory Drug Risk Awareness: Primary Results and Lessons Learned. J Eval Clin Pract. Published online 6/11/2014.  http://onlinelibrary.wiley.com/doi/10.1111/jep.12193/pdf.
  • M, Harrison DL, Miller MJ, Farmer KC, Thompson DM, Ng Y. Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program. Epilepsy Behav. 2014;34:109-115.
  • Schupbach RR, Sparrow ND, Harrison DL, Miller MJ. Participant Perspectives from the Indian Health Service Anticoagulation Training Program. Int J Clin Pharm. 2013;35:1091-8.
  • Mittal M, Harrison DL, Miller MJ, Brahm NC. National Antidepressant Prescribing in Children and Adolescents with Mental Health Disorders after a FDA Boxed Warning. Res Social Adm Pharm. Published online 20 November 2013.  http://dx.doi.org/10.1016/j.sapharm.2013.11.001.
  • Winchester BR, Watkins SC, Brahm N, Harrison DL, Miller MJ. Mental Health Treatment Associated with Community-Based Depression Screening: Considerations for Planning Multidisciplinary Collaborative Care. Ann Pharmacother. 2013;47:797-804.
  • Pham TT, Miller MJ, Harrison DL, Lloyd AE, Crosby, KM, Johnson JL. Cardiovascular Disease and Nonsteroidal Anti-inflammatory Drug Prescribing In the Midst of Evolving Guidelines. J Eval Clin Pract. 2013;19:1026-1034.
  • Schupbach RR, Bousum JM, Miller MJ. Demonstration of Anticoagulation Patient Self-testing Feasibility at an Indian Health Service Facility: A Case Series Analysis. Pharmacy Practice. 2013; 11(1): 30-37.
  • O’Neal KS, Crosby KM, Miller MJ, Murray KA, Condren M. Assessing health literacy practices in a community pharmacy environment: Experiences using the AHRQ Pharmacy Health Literacy Assessment Tool. Res Social Adm Pharm. 2013;9:564-596.
  • Collum JL, Marcy TR, Stevens EL, Burns CF, Miller MJ. Exploring patient expectations for pharmacist-provided literacy-sensitive communication. Res Social Adm Pharm.  2013;9:626-632.
  • Wang L, Miller MJ, Schmitt MR, Wen FK. Assessing readability formula differences with written health information materials: application, results, and recommendations. Res Social Adm Pharm. 2013;9:503-516.